ConductScience.org, home

Paper · 42100296

Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?

Blum K and 24 others. Br J Healthc Med Res, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM? Papers, record 42100296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42100296

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?
PubMed
Journal
Br J Healthc Med Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-22
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blum KKenneth
2Lewandrowski KUKai Uwe
3Lorio MPMorgan P
4Pinhasov AAlbert
5Mohankumar KKavya
6Sharafshah AAlireza
7Thanos PKPanayotis K
8Bowirrat AAbdalla
9Lindeau MMarco
10Dowling ÁÁlvaro

1 to 10 of 25Source PubMed

See all 25 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
I01 CX000479CSRD VAUnited StatesI01CX000479PubMedNIH RePORTER
R21 DA045640NIDA NIH HHSUnited StatesR21DA045640PubMedNIH RePORTER
R33 DA045640NIDA NIH HHSUnited StatesR33DA045640PubMedNIH RePORTER
R41 MD012318NIMHD NIH HHSUnited StatesR41MD012318PubMedNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130,198,022The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD).Int J Genom Data Min2018https://conductscience.org/library/papers/30198022PubMed
225,377,988The Gateway Hypothesis of substance abuse: developmental, biological and societal perspectives.Acta Paediatr2015https://conductscience.org/library/papers/25377988PubMed
326,306,329The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.J Reward Defic Syndr2015https://conductscience.org/library/papers/26306329PubMed
427,174,576Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.Curr Neuropharmacol2017https://conductscience.org/library/papers/27174576PubMed
514,594,742The serotonin system and spiritual experiences.Am J Psychiatry2003https://conductscience.org/library/papers/14594742PubMed
627,840,857Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.Austin Addict Sci2016https://conductscience.org/library/papers/27840857PubMed
727,814,639Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome.Front Biosci (Landmark Ed)2017https://conductscience.org/library/papers/27814639PubMed
826,052,556NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity.J Reward Defic Syndr2015https://conductscience.org/library/papers/26052556PubMed
928,033,474
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Subst Use Misuse2017https://conductscience.org/library/papers/28033474PubMed
104,631,379A possible relationship between the pineal gland and ethanol preference in the rat.Curr Ther Res Clin Exp1973https://conductscience.org/library/papers/4631379PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
COMT1,312PubTator's text mininghttps://conductscience.org/library/genes/1312NCBI Gene
DRD21,813PubTator's text mininghttps://conductscience.org/library/genes/1813NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42100296

GET https://conductscience.org/api/papers/v1/42100296/authors?page=2